Working… Menu

A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01873534
Recruitment Status : Terminated (Unable to recruit patients meeting the inclusion criteria)
First Posted : June 10, 2013
Last Update Posted : August 11, 2015
Davita Clinical Research
Information provided by (Responsible Party):
FerruMax Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 2014
Actual Study Completion Date : March 2014
Certification/Extension First Submitted : June 2, 2015